| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
David J Croyle is Chief Medical Officer at CJMB. David J Croyle's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $290K at current prices.
Historically, David J Croyle's trades have earned a below-average insider score of 26/100 across 4 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -64.3%.
Net of sales, the CJMB filings show accumulation of 74,375 shares.
David J Croyle has 4 Form 4 filings on record from February 2025 to March 2026, all as Chief Medical Officer at Callan JMB (CJMB), 2025–2026.
The 4 reported transactions were 4 open-market purchases.
Counted by filing, the open-market trades come to 4 purchases worth about $254K and no sales.
The largest open-market purchase was 25,000 shares of CJMB at an average $4.50 on March 27, 2025, about $113K. Twelve months later CJMB was down 71%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | CJMB Callan Jmb Inc. | Chief Medical Officer | Buy | 10,195 | $1.75 | $17,841.25 | +1.3% | -63.2% | - | |
| Mar 6, 2026 | CJMB Callan Jmb Inc. | Chief Medical Officer | Buy | 14,805 | $1.76 | $26,086.41 | +1.9% | -53.8% | - | |
| Mar 27, 2025 | CJMB Callan Jmb Inc. | Chief Medical Officer | Buy | 25,000 | $4.50 | $112,500.00 | +3.3% | +14.7% | -70.6% | |
| Feb 5, 2025 | CJMB Callan Jmb Inc. | Chief Medical Officer | Buy | 24,375 | $4.00 | $97,500.00 | New | +19.9% | -58.0% |